Healthcare Services Group Inc (HCSG)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 38,386 | 31,947 | 37,763 | 35,985 | 34,630 | 20,576 | 29,794 | 32,539 | 45,863 | 71,505 | 89,609 | 103,145 | 98,682 | 89,830 | 80,530 | 75,615 | 64,581 | 77,238 | 84,980 | 92,608 |
| Total stockholders’ equity | US$ in thousands | 456,616 | 441,733 | 450,589 | 440,572 | 418,279 | 422,076 | 437,845 | 446,637 | 452,677 | 480,205 | 488,304 | 493,102 | 480,461 | 464,750 | 449,687 | 438,179 | 460,305 | 455,299 | 449,648 | 442,549 |
| ROE | 8.41% | 7.23% | 8.38% | 8.17% | 8.28% | 4.87% | 6.80% | 7.29% | 10.13% | 14.89% | 18.35% | 20.92% | 20.54% | 19.33% | 17.91% | 17.26% | 14.03% | 16.96% | 18.90% | 20.93% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $38,386K ÷ $456,616K
= 8.41%
To analyze Healthcare Services Group, Inc.'s return on equity (ROE), we will look at the trend of ROE over the past eight quarters.
The ROE for Healthcare Services Group, Inc. has been relatively stable over the past two years, ranging from a low of 4.87% in Q3 2022 to a high of 8.41% in Q4 2023. The company's ROE has generally been in the mid-single digits to low eight percent range, indicating a moderate level of profitability generated from shareholders' equity.
In the most recent quarter, Q4 2023, the ROE increased to 8.41%, which was higher compared to the previous quarter. This improvement could be a positive sign of the company's ability to generate higher profits from the shareholders' equity that has been invested in the business.
Overall, Healthcare Services Group, Inc. has shown a consistent performance in terms of ROE, with fluctuations within a certain range over the past two years. Further analysis of the company's financial statements and business strategies would be necessary to gain a deeper understanding of the factors influencing its return on equity performance.